サンプルお申込み

お問い合わせ

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、薬剤賦形剤の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に薬剤賦形剤市場を分類しています。
本レポートでは世界の薬剤賦形剤市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Dowdupont、Roquette、Ashland、BASF、Kerry、Evonik Industries、Croda、Associated British Foods、Archer Daniels Midland、Lubrizol、Innophos Holdings、Wacker Chemie、Signet

レポートは薬剤賦形剤の主要生産者を調査し、主要地域や国の消費状況も提供します。薬剤賦形剤の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Solid Drugs
    Semisolid Drugs
    Liquid Drugs

用途別の市場セグメント：
    Organic Chemicals
    Inorganic Chemicals
    Others

本レポートの詳細内容
本レポートは、世界の薬剤賦形剤市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて薬剤賦形剤市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の薬剤賦形剤生産量、成長率、市場シェアを調査している。

二. 消費面では、薬剤賦形剤の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの薬剤賦形剤売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の薬剤賦形剤市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本薬剤賦形剤のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：薬剤賦形剤のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： 薬剤賦形剤の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける薬剤賦形剤の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章薬剤賦形剤メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：薬剤賦形剤の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：薬剤賦形剤の主要メーカーの概要を提供し、製品の説明と仕様、薬剤賦形剤の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：薬剤賦形剤の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Drug Excipients market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Drug Excipients, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Drug Excipients, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Drug Excipients, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug Excipients sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Drug Excipients market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Drug Excipients sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Dowdupont, Roquette, Ashland, BASF, Kerry, Evonik Industries, Croda, Associated British Foods and Archer Daniels Midland, etc.

Market Segmentation
By Company
    Dowdupont
    Roquette
    Ashland
    BASF
    Kerry
    Evonik Industries
    Croda
    Associated British Foods
    Archer Daniels Midland
    Lubrizol
    Innophos Holdings
    Wacker Chemie
    Signet

Segment by Type
    Solid Drugs
    Semisolid Drugs
    Liquid Drugs

Segment by Application
    Organic Chemicals
    Inorganic Chemicals
    Others

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Drug Excipients in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Drug Excipients manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Excipients sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Drug Excipients Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Solid Drugs
    Table 3. Major Manufacturers of Semisolid Drugs
    Table 4. Major Manufacturers of Liquid Drugs
    Table 5. Global Drug Excipients Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Drug Excipients Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Drug Excipients Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Drug Excipients Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Drug Excipients Revenue Market Share by Region (2019-2024)
    Table 10. Global Drug Excipients Revenue Market Share by Region (2025-2030)
    Table 11. Global Drug Excipients Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Drug Excipients Sales by Region (2019-2024) & (K MT)
    Table 13. Global Drug Excipients Sales by Region (2025-2030) & (K MT)
    Table 14. Global Drug Excipients Sales Market Share by Region (2019-2024)
    Table 15. Global Drug Excipients Sales Market Share by Region (2025-2030)
    Table 16. Global Drug Excipients Sales by Manufacturers (2019-2024) & (K MT)
    Table 17. Global Drug Excipients Sales Share by Manufacturers (2019-2024)
    Table 18. Global Drug Excipients Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Drug Excipients Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Drug Excipients, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Drug Excipients Price by Manufacturers 2019-2024 (USD/MT)
    Table 22. Global Drug Excipients Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Drug Excipients by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Excipients as of 2023)
    Table 24. Global Key Manufacturers of Drug Excipients, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Drug Excipients, Product Offered and Application
    Table 26. Global Key Manufacturers of Drug Excipients, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Drug Excipients Sales by Type (2019-2024) & (K MT)
    Table 29. Global Drug Excipients Sales by Type (2025-2030) & (K MT)
    Table 30. Global Drug Excipients Sales Share by Type (2019-2024)
    Table 31. Global Drug Excipients Sales Share by Type (2025-2030)
    Table 32. Global Drug Excipients Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global Drug Excipients Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global Drug Excipients Revenue Share by Type (2019-2024)
    Table 35. Global Drug Excipients Revenue Share by Type (2025-2030)
    Table 36. Drug Excipients Price by Type (2019-2024) & (USD/MT)
    Table 37. Global Drug Excipients Price Forecast by Type (2025-2030) & (USD/MT)
    Table 38. Global Drug Excipients Sales by Application (2019-2024) & (K MT)
    Table 39. Global Drug Excipients Sales by Application (2025-2030) & (K MT)
    Table 40. Global Drug Excipients Sales Share by Application (2019-2024)
    Table 41. Global Drug Excipients Sales Share by Application (2025-2030)
    Table 42. Global Drug Excipients Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Drug Excipients Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Drug Excipients Revenue Share by Application (2019-2024)
    Table 45. Global Drug Excipients Revenue Share by Application (2025-2030)
    Table 46. Drug Excipients Price by Application (2019-2024) & (USD/MT)
    Table 47. Global Drug Excipients Price Forecast by Application (2025-2030) & (USD/MT)
    Table 48. US & Canada Drug Excipients Sales by Type (2019-2024) & (K MT)
    Table 49. US & Canada Drug Excipients Sales by Type (2025-2030) & (K MT)
    Table 50. US & Canada Drug Excipients Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada Drug Excipients Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada Drug Excipients Sales by Application (2019-2024) & (K MT)
    Table 53. US & Canada Drug Excipients Sales by Application (2025-2030) & (K MT)
    Table 54. US & Canada Drug Excipients Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Drug Excipients Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Drug Excipients Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Drug Excipients Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Drug Excipients Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Drug Excipients Sales by Country (2019-2024) & (K MT)
    Table 60. US & Canada Drug Excipients Sales by Country (2025-2030) & (K MT)
    Table 61. Europe Drug Excipients Sales by Type (2019-2024) & (K MT)
    Table 62. Europe Drug Excipients Sales by Type (2025-2030) & (K MT)
    Table 63. Europe Drug Excipients Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe Drug Excipients Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe Drug Excipients Sales by Application (2019-2024) & (K MT)
    Table 66. Europe Drug Excipients Sales by Application (2025-2030) & (K MT)
    Table 67. Europe Drug Excipients Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Drug Excipients Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Drug Excipients Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Drug Excipients Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Drug Excipients Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Drug Excipients Sales by Country (2019-2024) & (K MT)
    Table 73. Europe Drug Excipients Sales by Country (2025-2030) & (K MT)
    Table 74. China Drug Excipients Sales by Type (2019-2024) & (K MT)
    Table 75. China Drug Excipients Sales by Type (2025-2030) & (K MT)
    Table 76. China Drug Excipients Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China Drug Excipients Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China Drug Excipients Sales by Application (2019-2024) & (K MT)
    Table 79. China Drug Excipients Sales by Application (2025-2030) & (K MT)
    Table 80. China Drug Excipients Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Drug Excipients Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Drug Excipients Sales by Type (2019-2024) & (K MT)
    Table 83. Asia Drug Excipients Sales by Type (2025-2030) & (K MT)
    Table 84. Asia Drug Excipients Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia Drug Excipients Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia Drug Excipients Sales by Application (2019-2024) & (K MT)
    Table 87. Asia Drug Excipients Sales by Application (2025-2030) & (K MT)
    Table 88. Asia Drug Excipients Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Drug Excipients Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Drug Excipients Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Drug Excipients Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Drug Excipients Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Drug Excipients Sales by Region (2019-2024) & (K MT)
    Table 94. Asia Drug Excipients Sales by Region (2025-2030) & (K MT)
    Table 95. Middle East, Africa and Latin America Drug Excipients Sales by Type (2019-2024) & (K MT)
    Table 96. Middle East, Africa and Latin America Drug Excipients Sales by Type (2025-2030) & (K MT)
    Table 97. Middle East, Africa and Latin America Drug Excipients Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Drug Excipients Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Drug Excipients Sales by Application (2019-2024) & (K MT)
    Table 100. Middle East, Africa and Latin America Drug Excipients Sales by Application (2025-2030) & (K MT)
    Table 101. Middle East, Africa and Latin America Drug Excipients Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Drug Excipients Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Drug Excipients Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Drug Excipients Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Drug Excipients Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Drug Excipients Sales by Country (2019-2024) & (K MT)
    Table 107. Middle East, Africa and Latin America Drug Excipients Sales by Country (2025-2030) & (K MT)
    Table 108. Dowdupont Company Information
    Table 109. Dowdupont Description and Major Businesses
    Table 110. Dowdupont Drug Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 111. Dowdupont Drug Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Dowdupont Recent Developments
    Table 113. Roquette Company Information
    Table 114. Roquette Description and Major Businesses
    Table 115. Roquette Drug Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 116. Roquette Drug Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Roquette Recent Developments
    Table 118. Ashland Company Information
    Table 119. Ashland Description and Major Businesses
    Table 120. Ashland Drug Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 121. Ashland Drug Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Ashland Recent Developments
    Table 123. BASF Company Information
    Table 124. BASF Description and Major Businesses
    Table 125. BASF Drug Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 126. BASF Drug Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. BASF Recent Developments
    Table 128. Kerry Company Information
    Table 129. Kerry Description and Major Businesses
    Table 130. Kerry Drug Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 131. Kerry Drug Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Kerry Recent Developments
    Table 133. Evonik Industries Company Information
    Table 134. Evonik Industries Description and Major Businesses
    Table 135. Evonik Industries Drug Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 136. Evonik Industries Drug Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Evonik Industries Recent Developments
    Table 138. Croda Company Information
    Table 139. Croda Description and Major Businesses
    Table 140. Croda Drug Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 141. Croda Drug Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Croda Recent Developments
    Table 143. Associated British Foods Company Information
    Table 144. Associated British Foods Description and Major Businesses
    Table 145. Associated British Foods Drug Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 146. Associated British Foods Drug Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Associated British Foods Recent Developments
    Table 148. Archer Daniels Midland Company Information
    Table 149. Archer Daniels Midland Description and Major Businesses
    Table 150. Archer Daniels Midland Drug Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 151. Archer Daniels Midland Drug Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Archer Daniels Midland Recent Developments
    Table 153. Lubrizol Company Information
    Table 154. Lubrizol Description and Major Businesses
    Table 155. Lubrizol Drug Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 156. Lubrizol Drug Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Lubrizol Recent Developments
    Table 158. Innophos Holdings Company Information
    Table 159. Innophos Holdings Description and Major Businesses
    Table 160. Innophos Holdings Drug Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 161. Innophos Holdings Drug Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Innophos Holdings Recent Developments
    Table 163. Wacker Chemie Company Information
    Table 164. Wacker Chemie Description and Major Businesses
    Table 165. Wacker Chemie Drug Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 166. Wacker Chemie Drug Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Wacker Chemie Recent Developments
    Table 168. Signet Company Information
    Table 169. Signet Description and Major Businesses
    Table 170. Signet Drug Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 171. Signet Drug Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Signet Recent Developments
    Table 173. Key Raw Materials Lists
    Table 174. Raw Materials Key Suppliers Lists
    Table 175. Drug Excipients Distributors List
    Table 176. Drug Excipients Customers List
    Table 177. Drug Excipients Market Trends
    Table 178. Drug Excipients Market Drivers
    Table 179. Drug Excipients Market Challenges
    Table 180. Drug Excipients Market Restraints
    Table 181. Research Programs/Design for This Report
    Table 182. Key Data Information from Secondary Sources
    Table 183. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drug Excipients Product Picture
    Figure 2. Global Drug Excipients Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Drug Excipients Market Share by Type in 2023 & 2030
    Figure 4. Solid Drugs Product Picture
    Figure 5. Semisolid Drugs Product Picture
    Figure 6. Liquid Drugs Product Picture
    Figure 7. Global Drug Excipients Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Drug Excipients Market Share by Application in 2023 & 2030
    Figure 9. Organic Chemicals
    Figure 10. Inorganic Chemicals
    Figure 11. Others
    Figure 12. Drug Excipients Report Years Considered
    Figure 13. Global Drug Excipients Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Drug Excipients Revenue 2019-2030 (US$ Million)
    Figure 15. Global Drug Excipients Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Drug Excipients Revenue Market Share by Region (2019-2030)
    Figure 17. Global Drug Excipients Sales 2019-2030 ((K MT)
    Figure 18. Global Drug Excipients Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada Drug Excipients Sales YoY (2019-2030) & (K MT)
    Figure 20. US & Canada Drug Excipients Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Drug Excipients Sales YoY (2019-2030) & (K MT)
    Figure 22. Europe Drug Excipients Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Drug Excipients Sales YoY (2019-2030) & (K MT)
    Figure 24. China Drug Excipients Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) Drug Excipients Sales YoY (2019-2030) & (K MT)
    Figure 26. Asia (excluding China) Drug Excipients Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Drug Excipients Sales YoY (2019-2030) & (K MT)
    Figure 28. Middle East, Africa and Latin America Drug Excipients Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Drug Excipients Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of Drug Excipients in the World: Market Share by Drug Excipients Revenue in 2023
    Figure 31. Global Drug Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Drug Excipients Sales Market Share by Type (2019-2030)
    Figure 33. Global Drug Excipients Revenue Market Share by Type (2019-2030)
    Figure 34. Global Drug Excipients Sales Market Share by Application (2019-2030)
    Figure 35. Global Drug Excipients Revenue Market Share by Application (2019-2030)
    Figure 36. US & Canada Drug Excipients Sales Market Share by Type (2019-2030)
    Figure 37. US & Canada Drug Excipients Revenue Market Share by Type (2019-2030)
    Figure 38. US & Canada Drug Excipients Sales Market Share by Application (2019-2030)
    Figure 39. US & Canada Drug Excipients Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Drug Excipients Revenue Share by Country (2019-2030)
    Figure 41. US & Canada Drug Excipients Sales Share by Country (2019-2030)
    Figure 42. U.S. Drug Excipients Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada Drug Excipients Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe Drug Excipients Sales Market Share by Type (2019-2030)
    Figure 45. Europe Drug Excipients Revenue Market Share by Type (2019-2030)
    Figure 46. Europe Drug Excipients Sales Market Share by Application (2019-2030)
    Figure 47. Europe Drug Excipients Revenue Market Share by Application (2019-2030)
    Figure 48. Europe Drug Excipients Revenue Share by Country (2019-2030)
    Figure 49. Europe Drug Excipients Sales Share by Country (2019-2030)
    Figure 50. Germany Drug Excipients Revenue (2019-2030) & (US$ Million)
    Figure 51. France Drug Excipients Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. Drug Excipients Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy Drug Excipients Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia Drug Excipients Revenue (2019-2030) & (US$ Million)
    Figure 55. China Drug Excipients Sales Market Share by Type (2019-2030)
    Figure 56. China Drug Excipients Revenue Market Share by Type (2019-2030)
    Figure 57. China Drug Excipients Sales Market Share by Application (2019-2030)
    Figure 58. China Drug Excipients Revenue Market Share by Application (2019-2030)
    Figure 59. Asia Drug Excipients Sales Market Share by Type (2019-2030)
    Figure 60. Asia Drug Excipients Revenue Market Share by Type (2019-2030)
    Figure 61. Asia Drug Excipients Sales Market Share by Application (2019-2030)
    Figure 62. Asia Drug Excipients Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Drug Excipients Revenue Share by Region (2019-2030)
    Figure 64. Asia Drug Excipients Sales Share by Region (2019-2030)
    Figure 65. Japan Drug Excipients Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea Drug Excipients Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan Drug Excipients Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia Drug Excipients Revenue (2019-2030) & (US$ Million)
    Figure 69. India Drug Excipients Revenue (2019-2030) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Drug Excipients Sales Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Drug Excipients Revenue Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Drug Excipients Sales Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Drug Excipients Revenue Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Drug Excipients Revenue Share by Country (2019-2030)
    Figure 75. Middle East, Africa and Latin America Drug Excipients Sales Share by Country (2019-2030)
    Figure 76. Brazil Drug Excipients Revenue (2019-2030) & (US$ Million)
    Figure 77. Mexico Drug Excipients Revenue (2019-2030) & (US$ Million)
    Figure 78. Turkey Drug Excipients Revenue (2019-2030) & (US$ Million)
    Figure 79. Israel Drug Excipients Revenue (2019-2030) & (US$ Million)
    Figure 80. GCC Countries Drug Excipients Revenue (2019-2030) & (US$ Million)
    Figure 81. Drug Excipients Value Chain
    Figure 82. Drug Excipients Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed